CAGNACCI, Angelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 44.791
AS - Asia 26.043
EU - Europa 23.453
SA - Sud America 4.431
AF - Africa 463
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 30
Totale 99.243
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 44.125
GB - Regno Unito 9.038
CN - Cina 7.694
SG - Singapore 7.159
HK - Hong Kong 3.850
IT - Italia 3.642
BR - Brasile 3.430
VN - Vietnam 2.673
DE - Germania 2.317
SE - Svezia 1.874
UA - Ucraina 1.839
FI - Finlandia 1.413
KR - Corea 1.034
RU - Federazione Russa 955
TR - Turchia 926
BD - Bangladesh 896
FR - Francia 886
BG - Bulgaria 665
IN - India 443
AR - Argentina 378
CA - Canada 279
ID - Indonesia 258
MX - Messico 194
IQ - Iraq 182
EC - Ecuador 177
NL - Olanda 137
ZA - Sudafrica 130
CO - Colombia 126
PK - Pakistan 110
ES - Italia 107
JP - Giappone 105
AE - Emirati Arabi Uniti 93
PL - Polonia 91
VE - Venezuela 91
IE - Irlanda 86
MA - Marocco 83
CL - Cile 81
PH - Filippine 69
MY - Malesia 61
SA - Arabia Saudita 59
LT - Lituania 54
EG - Egitto 53
PY - Paraguay 53
UZ - Uzbekistan 51
KE - Kenya 50
IR - Iran 46
BE - Belgio 40
JM - Giamaica 39
TN - Tunisia 39
PE - Perù 38
NP - Nepal 35
JO - Giordania 33
UY - Uruguay 33
KZ - Kazakistan 30
PT - Portogallo 30
CH - Svizzera 29
RO - Romania 29
TH - Thailandia 29
AZ - Azerbaigian 27
CR - Costa Rica 27
DZ - Algeria 26
AU - Australia 25
DO - Repubblica Dominicana 25
DK - Danimarca 24
EU - Europa 24
AL - Albania 22
AT - Austria 21
IL - Israele 20
BO - Bolivia 19
CZ - Repubblica Ceca 18
HN - Honduras 18
GR - Grecia 17
RS - Serbia 17
NI - Nicaragua 16
OM - Oman 16
BH - Bahrain 15
BY - Bielorussia 15
ET - Etiopia 15
TW - Taiwan 15
KG - Kirghizistan 14
TT - Trinidad e Tobago 14
LB - Libano 13
PA - Panama 13
QA - Qatar 13
PS - Palestinian Territory 12
SI - Slovenia 12
GE - Georgia 11
BA - Bosnia-Erzegovina 10
HR - Croazia 10
PR - Porto Rico 10
HU - Ungheria 9
NG - Nigeria 9
SK - Slovacchia (Repubblica Slovacca) 9
SN - Senegal 9
AM - Armenia 8
CY - Cipro 8
GT - Guatemala 8
LV - Lettonia 8
CI - Costa d'Avorio 7
KW - Kuwait 7
Totale 99.103
Salva come PNG Salva come JPEG
Città #
Southend 7.074
Singapore 4.345
Jacksonville 4.039
Santa Clara 4.001
Hong Kong 3.798
Fairfield 3.613
Ashburn 3.489
Dearborn 2.598
Hefei 2.590
Woodbridge 2.282
Chandler 2.083
Houston 1.765
Beijing 1.486
Wilmington 1.476
London 1.406
Seattle 1.240
Ann Arbor 1.236
Cambridge 1.150
Nyköping 1.120
Seoul 985
San Jose 970
Ho Chi Minh City 904
The Dalles 872
Princeton 760
Helsinki 758
Los Angeles 660
Sofia 656
Eugene 640
Hanoi 637
Council Bluffs 611
Modena 608
Lauterbourg 553
Dallas 511
New York 452
Milan 430
Izmir 428
Bremen 423
Chicago 423
Buffalo 411
San Diego 372
São Paulo 297
Shanghai 282
Moscow 243
Des Moines 185
Rome 175
Salt Lake City 149
Guangzhou 125
Haiphong 119
Da Nang 106
Norwalk 106
Orem 106
Miano 102
Rio de Janeiro 99
Frankfurt am Main 89
Jakarta 88
Kunming 87
Columbus 81
Dublin 81
Nanjing 78
Tokyo 77
Tampa 71
Atlanta 70
San Francisco 68
Baghdad 67
Belo Horizonte 67
Curitiba 64
Bologna 62
Brasília 62
Elk Grove Village 62
Brooklyn 61
Chennai 59
Quito 59
Toronto 58
Amsterdam 53
Boardman 53
Mexico City 53
Munich 53
Guayaquil 52
Biên Hòa 51
Johannesburg 51
San Mateo 51
Denver 50
Hải Dương 50
Dhaka 49
Tashkent 49
Montreal 47
Phoenix 46
Campinas 45
Verona 44
Dubai 43
Falls Church 43
Jinan 42
Manchester 42
Thái Bình 42
Warsaw 42
Falkenstein 41
Nairobi 41
Redwood City 41
Charlotte 40
Santiago 40
Totale 68.614
Salva come PNG Salva come JPEG
Nome #
The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome. 569
La melatonina aumenta la risposta delle gonadotropine al GnRH nelle donne in fase follicolare precoce, ma non nella fase luteale 418
Intensity of menstrual pain and estimated angle of uterine flexion 412
Diurnal variation of semen quality in human males. 391
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 374
Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain 361
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 354
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 347
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 344
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 341
Intermenstrual pelvic pain, quality of life and mood 334
Adenomyosis of the Extrapelvic Portion of the Round Ligament 331
Association between urinary incontinence and climacteric symptoms in postmenopausal women 330
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 322
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function 319
Differenza tra forma attiva (5-MTHF) e inattiva (acido folico) di folati sulla vasodilatazione di donne in postmenopausa 313
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 313
Lack of any estrogenic effect of ipriflavone in postmenopausal women. 304
Treatment of menopausal symptoms: concomitant modification of cortisol 303
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 302
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 302
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 301
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 300
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 299
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 299
Folate administration decreases oxidative status and blood pressure in postmenopausal women 298
Pharmacokinetic evaluation of desogestrel as a female contraceptive 295
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 291
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 291
Metabolic impact of combined hormonal contraceptives containing estradiol 290
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 287
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 285
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 283
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 283
Recommendations for contraception in women with diabetes. AMD-SIC position paper 282
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 278
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 278
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 276
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women 275
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 270
Season of birth influences the timing of menopause 266
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 266
Melatonin in relation to physiology in adult humans 265
Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study 260
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 259
Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. 257
Medical and patient attitude towards vaginal atrophy: the AGATA study 254
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 253
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 253
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 251
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 251
A role for melatonin in PCOS? 250
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 250
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 250
Prevalence of menstrual pain in young women: What is dysmenorrhea? 250
Prolonged melatonin administration decreases nocturnal blood pressure in women 249
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. 249
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 249
Amplification of pulsatile LH secretion by exogenous melatonin in women. 247
Conseguenze dell'Isterectomia associata o no ad ovariectomia nella donna 247
Melatonin: a major regulator of the circadian rhythm of core temperature in humans. 244
Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease. 242
Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement. 242
Anello Contraccettivo: i vantaggi della somministrazione vaginale 241
Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol 241
Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women. 240
Efficacia del nomegestrolo acetato, derivato del 19-Nor progesterone, nel trattamento dei sintomi premestruali: uso in casi selezionati con fase luteale inadeguata 238
Prolonged opioid blockade with naltrexone and luteinizing hormone modifications in women with polycystic ovarian syndrome. 237
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 234
Contraccettivi con soli progestinici in perimenopausa.Effetti sul dispendio energetico e composizione corporea 233
Melatonin enhances cortisol levels in aged but not young women. 232
Drospirenone: dati di sicurezza a lungo termine 232
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. 231
Pharmacological, metabolic and clinical aspects of new oral contraceptive associations containing natural estrogens [Aspetti farmacologici, metabolici e clinici delle nuove associazioni contraccettive a base di estrogeni naturali] 231
Seasonal trend of acute pelvic inflammatory disease 231
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 231
Amplification of pulsatile LH secretion by exogenous melatonin in women 231
Role of melatonin in circadian rhythm at menopause 230
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 228
Influence of melatonin and photoperiod on animal and human reproduction 227
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group* 227
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 227
Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women. 226
European society of contraception statement on contraception in obese women 226
Ovary Cystadenofibroma Associated with Didelphys Uterus in a Teenager: Conservative Laparoscopic Management 225
Hormone replacement therapy and glucose metabolism 224
Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. 223
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 223
A comparison of the central effects of different progestins used in hormone replacement therapy 223
Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. 220
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 220
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women. 219
Correlazione tra i livelli di omocisteina e densità minerale ossea in donne in postmenopausa. Uno studio longitudinale 219
Effetti dell’ HRT e SERM sulla pressione arteriosa 218
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 218
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women 217
Fattori implicati nel determinismo del sesso del nascituro 216
Blood pressure and cardiovascular risk factors in women treated for climacteric symptoms with acupuncture, phytoestrogens, or hormones 216
The effect of menopause on blood lipid and lipoprotein levels 214
Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women. 213
Totale 27.031
Salva come PNG Salva come JPEG
Categoria #
all - tutte 381.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 381.426
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.963 130 1.273 483 459 142 334 250 390 941 573 704 1.284
2022/20236.690 972 573 365 449 1.184 1.018 125 616 891 60 225 212
2023/20244.666 201 264 198 332 1.266 515 622 569 74 59 117 449
2024/202515.613 486 186 115 1.142 3.078 2.003 936 720 2.249 1.091 1.169 2.438
2025/202629.749 1.457 1.520 3.988 4.026 2.537 1.818 3.289 1.888 2.599 3.017 2.052 1.558
2026/20271.859 1.859 0 0 0 0 0 0 0 0 0 0 0
Totale 99.797